Stay updated on IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision label also updates from v3.7.1 to v3.7.2.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe study record page now displays a 403 Forbidden message, replacing the detailed study information, eligibility criteria, locations, and outcomes sections with a standard access-denied layout.SummaryDifference19%

- Check48 days agoChange DetectedA new page revision label appears, showing Revision: v3.7.0 in place of Revision: v3.6.6, indicating a minor update to the page template or metadata.SummaryDifference0.0%

- Check62 days agoChange DetectedA new page revision tag 'Revision: v3.6.6' was added. The previous revision tag 'Revision: v3.6.5' was removed.SummaryDifference0.0%

- Check69 days agoChange DetectedA line noting '2017 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH funding for MOR106-CL-201. This change represents funding metadata and does not affect the study's design or eligibility criteria.SummaryDifference0.0%

Stay in the know with updates to IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.